Cholangioscopy by Using Narrow-Band Imaging and Transpapillary Radiotherapy for Mucin-Producing Bile Duct Tumor.
Xin–Liang Lu,Takao Itoi,Kensuke Kubota
DOI: https://doi.org/10.1016/j.cgh.2008.11.001
IF: 13.576
2009-01-01
Clinical Gastroenterology and Hepatology
Abstract:See related article, Hida S et al, on page xx in this issue of CGH.A 78-year-old man was hospitalized because of recurrent cholangitis of 5 years' duration. Laboratory tests showed elevated liver function test results. A computed tomography scan of the abdomen showed a dilated common bile duct. Duodenoscopy showed voluminous mucin excreted from the papillary orifice (Figure A). Cholangiography revealed a dilated common bile duct with large amorphous filling defects suspected to be due to mucin (Figure A). Bile cytology revealed adenoma. Peroral videocholangioscopy (POCS) showed papillary mucosal lesions located between the superior common bile duct and left hepatic duct (Figure B). Narrow-band imaging (NBI) provided better view of the margin of the lesion and better observation of vessels on the surface of the lesion (Figure B) (Video Clip 1). A biopsy of the lesion revealed mucinous tumor on histopathology.Because the patient refused surgical intervention, we performed transpapillary intraluminal radiotherapy (TIRT) by using a remote-controlled after-loading system (RALS). After placement of a 10F endoscopic nasobiliary drainage (ENBD) tube (ENBD-10; Wilson-Cook Medical Inc, Winston-Salem, NC), iridium 192 high-dose rate intraluminal radiotherapy (1-mm diameter, VS-2000; Varian Medical Systems, Inc, Palo Alto, CA) was delivered by microselection remote-controlled brachy unit therapy (Varisource; Varian Medical Systems, Inc). The radiation dose was 6 Gy in 1-cm reference point once a week for 5 weeks. After 3 sessions of TIRT, a stent was not required because mucin production had decreased (Figure C). At repeat endoscopic retrograde cholangiopancreatography and POCS (Figure C) at 1-month follow-up, the bile duct was free of neoplastic lesions.DiscussionIntraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is characterized by innumerable papillary lesions.1Lim J.H. Yoon K.H. Kim S.H. et al.Intraductal papillary mucinous tumor of the bile ducts.Radiographics. 2004; 24: 53-66Crossref PubMed Scopus (110) Google Scholar Occasionally, IPMN-B produces a large amount of mucin that disturbs bile flow and causes recurrent cholangitis. It is difficult to manage refractory cholangitis in IPMN-B patients in whom surgery is not indicated.This is a report of TIRT for successful palliative therapy of IPMN-B that caused recurrent bouts of cholangitis caused by a clot of mucin, causing rapid stent occlusion. Previously we have performed percutaneous intraluminal radiotherapy to reduce a large amount of mucin in patients with IPMN-B.2Itoi T. Sofuni A. Itokawa F. et al.Salvage therapy in patients with unresectable hilar cholangiocarcinoma.Dig Endosc. 2006; 18: 232-238Crossref Scopus (2) Google Scholar Recently, because an ultrathin flexible probe for radiation therapy has been developed, we have been trying to perform transpapillary rather than percutaneous radiotherapy for bile duct neoplasia because of its convenience. Interestingly, Brauer et al3Brauer B.C. Fukami N. Chen Y.K. Direct cholangioscopy with narrow-band imaging, chromoendoscopy, and argon plasma coagulation of intraductal papillary mucinous neoplasm of the bile duct (with videos).Gastrointest Endosc. 2008; 67: 574-576Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar reported that argon plasma coagulation was effective for IPMN-B, although the size of their lesions was small. We consider TIRT to be better for therapy of IPMN-B with wide tumor margins because en bloc ablation can be achieved in a circumferential manner. At present, however, the optimal total radiation doses are not yet established for IPMN-B with wide tumor margins; in the present case the entire neoplastic lesion was ablated with 30 Gy radiation. However, long-term follow-up is required to assess durable response to therapy.A large amount of mucin produced by IPMN-B frequently hinders location of the tumor. However, accurate diagnosis and location of the tumor are mandatory for the selection of therapeutic strategy. In the present case, we diagnosed the tumor extent by using videocholangioscopy in combination with NBI. As we previously described, videocholangioscopy and NBI are useful to visualize the mucosal structures and mucosal microvessels in patients with pancreaticobiliary diseases.4Itoi T. Sofuni A. Itokawa F. et al.Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos).Gastrointest Endosc. 2007; 66: 730-736Abstract Full Text Full Text PDF PubMed Scopus (151) Google ScholarIn conclusion, the gold standard therapy for IPMN-B is surgery. However, in unresectable cases, our report suggests that tumor ablation by TIRT could help manage recurrent and difficult cholangitis caused by IPMN-B, although further study is needed. See related article, Hida S et al, on page xx in this issue of CGH. See related article, Hida S et al, on page xx in this issue of CGH. See related article, Hida S et al, on page xx in this issue of CGH. A 78-year-old man was hospitalized because of recurrent cholangitis of 5 years' duration. Laboratory tests showed elevated liver function test results. A computed tomography scan of the abdomen showed a dilated common bile duct. Duodenoscopy showed voluminous mucin excreted from the papillary orifice (Figure A). Cholangiography revealed a dilated common bile duct with large amorphous filling defects suspected to be due to mucin (Figure A). Bile cytology revealed adenoma. Peroral videocholangioscopy (POCS) showed papillary mucosal lesions located between the superior common bile duct and left hepatic duct (Figure B). Narrow-band imaging (NBI) provided better view of the margin of the lesion and better observation of vessels on the surface of the lesion (Figure B) (Video Clip 1). A biopsy of the lesion revealed mucinous tumor on histopathology. Because the patient refused surgical intervention, we performed transpapillary intraluminal radiotherapy (TIRT) by using a remote-controlled after-loading system (RALS). After placement of a 10F endoscopic nasobiliary drainage (ENBD) tube (ENBD-10; Wilson-Cook Medical Inc, Winston-Salem, NC), iridium 192 high-dose rate intraluminal radiotherapy (1-mm diameter, VS-2000; Varian Medical Systems, Inc, Palo Alto, CA) was delivered by microselection remote-controlled brachy unit therapy (Varisource; Varian Medical Systems, Inc). The radiation dose was 6 Gy in 1-cm reference point once a week for 5 weeks. After 3 sessions of TIRT, a stent was not required because mucin production had decreased (Figure C). At repeat endoscopic retrograde cholangiopancreatography and POCS (Figure C) at 1-month follow-up, the bile duct was free of neoplastic lesions. DiscussionIntraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is characterized by innumerable papillary lesions.1Lim J.H. Yoon K.H. Kim S.H. et al.Intraductal papillary mucinous tumor of the bile ducts.Radiographics. 2004; 24: 53-66Crossref PubMed Scopus (110) Google Scholar Occasionally, IPMN-B produces a large amount of mucin that disturbs bile flow and causes recurrent cholangitis. It is difficult to manage refractory cholangitis in IPMN-B patients in whom surgery is not indicated.This is a report of TIRT for successful palliative therapy of IPMN-B that caused recurrent bouts of cholangitis caused by a clot of mucin, causing rapid stent occlusion. Previously we have performed percutaneous intraluminal radiotherapy to reduce a large amount of mucin in patients with IPMN-B.2Itoi T. Sofuni A. Itokawa F. et al.Salvage therapy in patients with unresectable hilar cholangiocarcinoma.Dig Endosc. 2006; 18: 232-238Crossref Scopus (2) Google Scholar Recently, because an ultrathin flexible probe for radiation therapy has been developed, we have been trying to perform transpapillary rather than percutaneous radiotherapy for bile duct neoplasia because of its convenience. Interestingly, Brauer et al3Brauer B.C. Fukami N. Chen Y.K. Direct cholangioscopy with narrow-band imaging, chromoendoscopy, and argon plasma coagulation of intraductal papillary mucinous neoplasm of the bile duct (with videos).Gastrointest Endosc. 2008; 67: 574-576Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar reported that argon plasma coagulation was effective for IPMN-B, although the size of their lesions was small. We consider TIRT to be better for therapy of IPMN-B with wide tumor margins because en bloc ablation can be achieved in a circumferential manner. At present, however, the optimal total radiation doses are not yet established for IPMN-B with wide tumor margins; in the present case the entire neoplastic lesion was ablated with 30 Gy radiation. However, long-term follow-up is required to assess durable response to therapy.A large amount of mucin produced by IPMN-B frequently hinders location of the tumor. However, accurate diagnosis and location of the tumor are mandatory for the selection of therapeutic strategy. In the present case, we diagnosed the tumor extent by using videocholangioscopy in combination with NBI. As we previously described, videocholangioscopy and NBI are useful to visualize the mucosal structures and mucosal microvessels in patients with pancreaticobiliary diseases.4Itoi T. Sofuni A. Itokawa F. et al.Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos).Gastrointest Endosc. 2007; 66: 730-736Abstract Full Text Full Text PDF PubMed Scopus (151) Google ScholarIn conclusion, the gold standard therapy for IPMN-B is surgery. However, in unresectable cases, our report suggests that tumor ablation by TIRT could help manage recurrent and difficult cholangitis caused by IPMN-B, although further study is needed. Intraductal papillary mucinous neoplasm of the bile duct (IPMN-B) is characterized by innumerable papillary lesions.1Lim J.H. Yoon K.H. Kim S.H. et al.Intraductal papillary mucinous tumor of the bile ducts.Radiographics. 2004; 24: 53-66Crossref PubMed Scopus (110) Google Scholar Occasionally, IPMN-B produces a large amount of mucin that disturbs bile flow and causes recurrent cholangitis. It is difficult to manage refractory cholangitis in IPMN-B patients in whom surgery is not indicated. This is a report of TIRT for successful palliative therapy of IPMN-B that caused recurrent bouts of cholangitis caused by a clot of mucin, causing rapid stent occlusion. Previously we have performed percutaneous intraluminal radiotherapy to reduce a large amount of mucin in patients with IPMN-B.2Itoi T. Sofuni A. Itokawa F. et al.Salvage therapy in patients with unresectable hilar cholangiocarcinoma.Dig Endosc. 2006; 18: 232-238Crossref Scopus (2) Google Scholar Recently, because an ultrathin flexible probe for radiation therapy has been developed, we have been trying to perform transpapillary rather than percutaneous radiotherapy for bile duct neoplasia because of its convenience. Interestingly, Brauer et al3Brauer B.C. Fukami N. Chen Y.K. Direct cholangioscopy with narrow-band imaging, chromoendoscopy, and argon plasma coagulation of intraductal papillary mucinous neoplasm of the bile duct (with videos).Gastrointest Endosc. 2008; 67: 574-576Abstract Full Text Full Text PDF PubMed Scopus (57) Google Scholar reported that argon plasma coagulation was effective for IPMN-B, although the size of their lesions was small. We consider TIRT to be better for therapy of IPMN-B with wide tumor margins because en bloc ablation can be achieved in a circumferential manner. At present, however, the optimal total radiation doses are not yet established for IPMN-B with wide tumor margins; in the present case the entire neoplastic lesion was ablated with 30 Gy radiation. However, long-term follow-up is required to assess durable response to therapy. A large amount of mucin produced by IPMN-B frequently hinders location of the tumor. However, accurate diagnosis and location of the tumor are mandatory for the selection of therapeutic strategy. In the present case, we diagnosed the tumor extent by using videocholangioscopy in combination with NBI. As we previously described, videocholangioscopy and NBI are useful to visualize the mucosal structures and mucosal microvessels in patients with pancreaticobiliary diseases.4Itoi T. Sofuni A. Itokawa F. et al.Peroral cholangioscopic diagnosis of biliary-tract diseases by using narrow-band imaging (with videos).Gastrointest Endosc. 2007; 66: 730-736Abstract Full Text Full Text PDF PubMed Scopus (151) Google Scholar In conclusion, the gold standard therapy for IPMN-B is surgery. However, in unresectable cases, our report suggests that tumor ablation by TIRT could help manage recurrent and difficult cholangitis caused by IPMN-B, although further study is needed. Supplementary data Download .mpg (6.36 MB) Help with mpg files Video Clip 1 Download .mpg (6.36 MB) Help with mpg files Video Clip 1 Eosinophilic Esophagitis With Gastric HeterotopiaClinical Gastroenterology and HepatologyVol. 7Issue 6PreviewEosinophilic esophagitis increasingly is being diagnosed and often first noted at food impaction. We present the occurrence of eosinophilic esophagitis presenting together with a gastric heterotopic (inlet) patch. Full-Text PDF